logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabNecrotising myositis associated with erythematous rash: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2019年 / 1743卷 / 1期
关键词:
D O I:
10.1007/s40278-019-58817-5
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:129 / 129
相关论文
共 50 条
  • [1] Ipilimumab/nivolumabEosinophilia, erythematous rash and pruritus: case report
    Reactions Weekly, 2023, 1961 (1) : 235 - 235
  • [2] CyanoacrylateItchy, erythematous rash: case report
    Reactions Weekly, 2018, 1724 (1) : 128 - 128
  • [3] DasatinibEdematous and erythematous rash: case report
    Reactions Weekly, 2023, 1964 (1) : 157 - 157
  • [4] KetamineMorbilliform and erythematous rash: case report
    Reactions Weekly, 2017, 1653 (1) : 186 - 186
  • [5] Ipilimumab/nivolumabKeratoacanthomas and rash: case report
    Reactions Weekly, 2025, 2056 (1) : 264 - 264
  • [6] Ipilimumab/pembrolizumabInflammatory myositis: case report
    Reactions Weekly, 2019, 1753 (1) : 205 - 205
  • [7] ChlorhexidineBurning sensation and erythematous rash: case report
    Reactions Weekly, 2015, 1534 (1) : 48 - 48
  • [8] LithiumDiffuse erythematous maculopapular rash: case report
    Reactions Weekly, 2017, 1662 (1) : 237 - 237
  • [9] CeftazidimeGeneralised erythematous maculopapular rash: case report
    Reactions Weekly, 2022, 1917 (1) : 163 - 163
  • [10] CytarabineCorneal microcysts and erythematous rash: case report
    Reactions Weekly, 2015, 1565 (1) : 89 - 89
← 12345 →